Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Mansour, E. Kochetkova, N. Santelmo, M. Pruyt, R. Kessler, J. M. Wihlm, E. Quoix, G. Massard (Strasbourg, France). Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy. Eur Respir J 2007; 30: Suppl. 51, 1765

Member's Comments

No comment yet.

Related content which might interest you: Bronchopleural fistula-risk factors and treatment after lung cancer surgery Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007 The surgical treatment of lung cancer Source: Eur Respir Mon; 2009: 44: 187–206 Year: 2009 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009 Can we still justify pneumonectomy following induction chemotherapy? Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 High postoperative risk after pneumonectomy in elderly patients with right-sided lung cancer Source: Eur Respir J 2002; 19: 141-145 Year: 2002 Surgical treatment of locally recurrent lung cancer Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer Source: International Congress 2017 – Thoracic surgery Year: 2017 Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001 Complications following pneumonectomy in patients with lung cancer and associated cardiopulmonary pathology Source: Eur Respir J 2002; 20: Suppl. 38, 462s Year: 2002 Outcome after pneumonectomy in non small cell lung cancer patients receiving a neoadjuvant therapy Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004 Impact of neoadjuvant therapies on surgical indications and early postoperative outcome Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Balanced indications for surgery or endobronchial therapy for typical carcinoid tumours Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 Smoking status in patients who pneumonectomy was performed as treatment for lung cancer Source: Annual Congress 2010 - Epidemiological data for smoking control Year: 2010 Possibilities of predicting cardiorespiratory complications in patients underwent pneumonectomy for non small-cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002 Postoperative lung cancer relapse after chemoradiation therapy Source: International Congress 2014 – Thoracic oncology grand round - an interactive session Year: 2014 Optimising treatment for post-operative lung cancer recurrence Source: Eur Respir J 2016; 47: 374-378 Year: 2016 Survival and postoperative complication after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer: a balancing exercise Source: Eur Respir J 2003; 22: Suppl. 45, 31s Year: 2003